For your right to be curious.

Donate

Play Live Radio

Next Up:

0:00

0:00 0:00

Available On Air Stations

Build a transformational philanthropy program for this trusted NPR affiliate.
Seeking a 100% major gift fundraiser passionate about public media to develop relationships with people who support an informed and civil central Illinois.
Hire will have community visibility, many prospects, and professional resources.
Interviews in progress, open until filled. Apply now.

What a new pancreatic cancer drug means for patients

WBUR | By Here & Now Newsroom

Published June 12, 2026 at 10:59 AM CDT

A new pancreatic cancer drug is now being offered to patients outside of clinical trials. Daraxonrasib is an experimental pill that doubled survival time compared to standard chemotherapy, according to the results of a clinical trial.

Ed Silverman, a columnist and senior writer at STAT, joins us to discuss what this new drug means for pancreatic cancer patients.

This article was originally published on WBUR.org.

Here & Now Newsroom